ReviewCancers2026

Efficacy and Toxicity in Scheduled Intravesical Gemcitabine Versus Bacillus Calmette-Guérin for Bladder Cancer: A Systematic Review and Meta-Analysis.

Do Kyung Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.